499 results on '"Spillane, Andrew J."'
Search Results
2. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas
3. The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort
4. ASO Author Reflections: Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas
5. ASO Visual Abstract: The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma: An Australian Cohort
6. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
7. ASO Visual Abstract: Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas
8. ASO Visual Abstract: Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
9. Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
10. Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study
11. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
12. Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
13. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
14. Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
15. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
16. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
17. Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework
18. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
19. Histological regression in melanoma: impact on sentinel lymph node status and survival
20. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
21. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma
22. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
23. Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
24. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
25. Primary dermal melanoma: clinical behaviour, prognosis and treatment
26. Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management
27. Current bi‐national attitudes towards targeted axillary dissection
28. Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study
29. Benefits and harms of breast cancer screening revisited: a large, retrospective cross-sectional study quantifying treatment intensity in women with screen-detected versus non-screen-detected cancer in Australia and New Zealand
30. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma
31. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
32. The complexities of establishing a surgical multi‐centre registry in Australia: challenges, and possible solution.
33. Surgical Technique for Open Inguinal Lymphadenectomy
34. Evaluation of a structured clinical program and formal coursework in breast surgeon training in Australia and New Zealand
35. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
36. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
37. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
38. Breast symptoms in adolescents and young adults presenting to a specialist breast clinic
39. ASO Visual Abstract: Survival Outcomes of Salvage Metastasectomy after Failure of Modern-Era Systemic Therapy for Melanoma
40. Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens
41. Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center
42. Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival
43. Impact of selective use of breast MRI on surgical decision-making in women with newly diagnosed operable breast cancer
44. Patient-reported outcomes in ductal carcinoma in situ: A systematic review
45. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
46. Immediate expander/implant breast reconstruction followed by post-mastectomy radiotherapy for breast cancer: Aesthetic, surgical, satisfaction and quality of life outcomes in women with high-risk breast cancer
47. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
48. Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
49. Abstract 81: The association between melanoma liver metastases (mets) and the systemic anti-tumor immune profile
50. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.